Intercept Pharma (ICPT) Misses Q1 EPS by 9c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Intercept Pharma (ICPT) Misses Q1 EPS by 9c

Intercept Pharmaceuticals Announces First Quarter 2015 Financial Results

May 11, 2015 6:01 AM EDT

NEW YORK, May 11, 2015 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat neglected chronic liver diseases, today reported financial results for the first quarter ended March 31, 2015. Intercept will hold a conference call and audio webcast today at 9:45 a.m. ET to review this information. Conference call details are provided below.

First Quarter 2015 Financial Results

Intercept reported a net loss of $39.4 million, or $1.78 per share, for the first quarter of 2015 compared to a net... More